We are live on
!
Find out more
GVI
Green Valley Investors Portfolio holdings
AUM
$1.76B
1-Year Est. Return
5.64%
This Fund
S&P 500
This Quarter
Est. Return
+4.04%
1 Year Est. Return
+5.64%
3 Year Est. Return
+59.43%
5 Year Est. Return
+81.11%
10 Year Est. Return
–
AUM
$2.05B
AUM Growth
+$20.8M
(+1%)
Cap. Flow
-$44.2M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
63.27%
Holding
30
New
1
Increased
5
Reduced
23
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kraft Heinz
KHC
|
+$27.3M |
| 2 |
O'Reilly Automotive
ORLY
|
+$18.8M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$18.2M |
| 4 |
UnitedHealth
UNH
|
+$14.7M |
| 5 |
Nike
NKE
|
+$9.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$49.8M |
| 2 |
Gilead Sciences
GILD
|
+$10.2M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$9.72M |
| 4 |
International Flavors & Fragrances
IFF
|
+$8.38M |
| 5 |
CELG
Celgene Corp
CELG
|
+$6.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.6% |
| 2 | Consumer Discretionary | 27.39% |
| 3 | Materials | 7.31% |
| 4 | Consumer Staples | 7.05% |
| 5 | Communication Services | 4.64% |
Similar funds
GMI
BA
AWM
CA
CC
STMM
RCM
BCMNY
Green Valley Investors's Q2 2017 Portfolio in Review
As of Q2 2017, Green Valley Investors held 30 positions worth $2.05B, up 1% from $2.03B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Green Valley Investors's Q2 2017 filing shows 1 new, 5 increased, 23 reduced and 1 closed positions. Its largest new stake was Exact Sciences: 590,684 shares worth $20.9M. The largest sale was Allergan plc, an estimated $49.8M.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 55% a quarter earlier, followed by Consumer Discretionary and Materials.
- Green Valley Investors's largest Q2 2017 buy was Exact Sciences: 590,684 shares worth $20.9M.
- Green Valley Investors added most to Kraft Heinz in Q2 2017, an estimated $27.3M increase.
- Green Valley Investors's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $10.2M.
- Green Valley Investors fully exited Allergan plc in Q2 2017, selling an estimated $49.8M.
- Green Valley Investors's ten largest holdings make up 63% of its $2.05B portfolio in Q2 2017.
- Green Valley Investors opened 1 new position and closed 1 in Q2 2017.
- Green Valley Investors's portfolio value rose 1% quarter-over-quarter to $2.05B.
Based on Green Valley Investors's 13F filing for Q2 2017, filed 10 Aug 2017.